DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Schwab N, Schneider-Hohendorf T, Melzer N. et al.
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.
Neurology 2017;
88: 1197-1205
We do not assume any responsibility for the contents of the web pages of other providers.